As of 2025-08-04, the Relative Valuation of Apellis Pharmaceuticals Inc (APLS) is (38.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.95 USD, the upside of Apellis Pharmaceuticals Inc based on Relative Valuation is -268.3%.
The range of the Relative Valuation is (31.39) - (43.07) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 24.2x | 20.2x |
| Forward P/E multiples | 17.6x - 28.9x | 23.2x |
| Fair Price | (31.39) - (43.07) | (38.62) |
| Upside | -236.8% - -287.7% | -268.3% |
| Date | P/E |
| 2025-08-01 | -12.90 |
| 2025-07-31 | -12.55 |
| 2025-07-30 | -10.68 |
| 2025-07-29 | -10.65 |
| 2025-07-28 | -10.54 |
| 2025-07-25 | -11.01 |
| 2025-07-24 | -11.29 |
| 2025-07-23 | -11.18 |
| 2025-07-22 | -11.18 |
| 2025-07-21 | -10.83 |
| 2025-07-18 | -10.94 |
| 2025-07-17 | -11.26 |
| 2025-07-16 | -11.10 |
| 2025-07-15 | -10.87 |
| 2025-07-14 | -11.19 |
| 2025-07-11 | -10.92 |
| 2025-07-10 | -10.97 |
| 2025-07-09 | -10.79 |
| 2025-07-08 | -10.05 |
| 2025-07-07 | -9.79 |
| 2025-07-03 | -10.26 |
| 2025-07-02 | -10.01 |
| 2025-07-01 | -10.04 |
| 2025-06-30 | -9.73 |
| 2025-06-27 | -9.79 |
| 2025-06-26 | -10.34 |
| 2025-06-25 | -10.33 |
| 2025-06-24 | -10.46 |
| 2025-06-23 | -9.90 |
| 2025-06-20 | -9.94 |
| 2025-06-18 | -9.98 |
| 2025-06-17 | -9.98 |
| 2025-06-16 | -10.28 |
| 2025-06-13 | -10.58 |
| 2025-06-12 | -10.82 |
| 2025-06-11 | -10.83 |
| 2025-06-10 | -11.00 |
| 2025-06-09 | -10.89 |
| 2025-06-06 | -10.83 |
| 2025-06-05 | -10.73 |
| 2025-06-04 | -10.40 |
| 2025-06-03 | -10.57 |
| 2025-06-02 | -10.75 |
| 2025-05-30 | -9.51 |
| 2025-05-29 | -9.78 |
| 2025-05-28 | -9.44 |
| 2025-05-27 | -9.49 |
| 2025-05-23 | -9.80 |
| 2025-05-22 | -9.99 |
| 2025-05-21 | -9.79 |